Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.
2.

Testicular mixed germ cell tumor presenting with seizure as the initial symptom: a case report and literature review.

Syu SH, Chang CL, Shih HJ.

Int Braz J Urol. 2019 Mar 22;45. doi: 10.1590/S1677-5538.IBJU.2018.0523. [Epub ahead of print]

PMID:
30912892
3.

Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues.

Yu HH, Chengchuan Ko E, Chang CL, Yuan KS, Wu ATH, Shan YS, Wu SY.

Mar Drugs. 2018 Oct 19;16(10). pii: E392. doi: 10.3390/md16100392.

4.

Treatment outcomes for unresectable intrahepatic cholangiocarcinoma: Nationwide, population-based, cohort study based on propensity score matching with the Mahalanobis metric.

Chang WW, Hsiao PK, Qin L, Chang CL, Chow JM, Wu SY.

Radiother Oncol. 2018 Nov;129(2):284-292. doi: 10.1016/j.radonc.2018.09.010. Epub 2018 Sep 29.

PMID:
30279046
5.

Intensity-modulated radiotherapy with systemic chemotherapy improves survival in patients with nonmetastatic unresectable pancreatic adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study.

Lin YK, Hsieh MC, Chang CL, Chow JM, Yuan KS, Wu ATH, Wu SY.

Radiother Oncol. 2018 Nov;129(2):326-332. doi: 10.1016/j.radonc.2018.07.012. Epub 2018 Aug 3.

PMID:
30082144
6.

Outcomes of adjuvant treatments for resectable intrahepatic cholangiocarcinoma: Chemotherapy alone, sequential chemoradiotherapy, or concurrent chemoradiotherapy.

Lin YK, Hsieh MC, Wang WW, Lin YC, Chang WW, Chang CL, Cheng YF, Wu SY.

Radiother Oncol. 2018 Sep;128(3):575-583. doi: 10.1016/j.radonc.2018.05.011. Epub 2018 May 22.

PMID:
29801723
7.

Efficacy of thoracic radiotherapy in patients with stage IIIB-IV epidermal growth factor receptor-mutant lung adenocarcinomas who received and responded to tyrosine kinase inhibitor treatment.

Yen YC, Hsu HL, Chang JH, Lin WC, Chang YC, Chang CL, Chow JM, Yuan KS, Wu ATH, Wu SY.

Radiother Oncol. 2018 Oct;129(1):52-60. doi: 10.1016/j.radonc.2018.03.007. Epub 2018 Apr 24.

PMID:
29703499
8.

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy.

Hsieh MC, Chang WW, Yu HH, Lu CY, Chang CL, Chow JM, Chen SU, Cheng Y, Wu SY.

Cancer Med. 2018 Jun;7(6):2328-2338. doi: 10.1002/cam4.1479. Epub 2018 Apr 17.

9.

Treatment of advanced nasopharyngeal cancer using low- or high-dose concurrent chemoradiotherapy with intensity-modulated radiotherapy: A propensity score-matched, nationwide, population-based cohort study.

Chen TM, Lin KC, Yuan KS, Chang CL, Chow JM, Wu SY.

Radiother Oncol. 2018 Oct;129(1):23-29. doi: 10.1016/j.radonc.2017.12.004. Epub 2017 Dec 22.

PMID:
29277447
10.

Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma.

Chang CL, Tsai HC, Lin WC, Chang JH, Hsu HL, Chow JM, Yuan KS, Wu ATH, Wu SY.

Radiother Oncol. 2017 Oct;125(1):73-79. doi: 10.1016/j.radonc.2017.08.025. Epub 2017 Sep 17.

PMID:
28923576
11.

Induction of Forkhead Class box O3a and apoptosis by a standardized ginsenoside formulation, KG-135, is potentiated by autophagy blockade in A549 human lung cancer cells.

Yao CJ, Chow JM, Chuang SE, Chang CL, Yan MD, Lee HL, Lai IC, Lin PC, Lai GM.

J Ginseng Res. 2017 Jul;41(3):247-256. doi: 10.1016/j.jgr.2016.04.003. Epub 2016 Apr 15.

12.

Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.

Lin WC, Ding YF, Hsu HL, Chang JH, Yuan KS, Wu ATH, Chow JM, Chang CL, Chen SU, Wu SY.

Cancer. 2017 Oct 15;123(20):3904-3915. doi: 10.1002/cncr.30823. Epub 2017 Jun 13.

13.

Cyproheptadine use in hepatocellular carcinoma.

Hsieh MC, Lee WH, Wu AT, Chow JM, Chang CL, Yuan KS, Wu SY.

Am J Cancer Res. 2017 Mar 1;7(3):584-602. eCollection 2017.

14.

High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.

Chang CL, Yuan KS, Wu SY.

Head Neck. 2017 Jul;39(7):1364-1370. doi: 10.1002/hed.24763. Epub 2017 Mar 28.

PMID:
28370614
15.

Polypoid lesions from the oesophagus to colon.

Huang PJ, Chang CL, Suk FM.

Gut. 2018 Mar;67(3):552. doi: 10.1136/gutjnl-2016-313663. Epub 2017 Feb 7. No abstract available.

PMID:
28174200
16.

Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.

Yen YC, Chang JH, Lin WC, Chiou JF, Chang YC, Chang CL, Hsu HL, Chow JM, Yuan KS, Wu ATH, Wu SY.

Cancer. 2017 Jun 1;123(11):2043-2053. doi: 10.1002/cncr.30565. Epub 2017 Feb 2.

17.

Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma.

Chen JH, Yen YC, Chen TM, Yuan KS, Lee FP, Lin KC, Lai MT, Wu CC, Chang CL, Wu SY.

Cancer Med. 2017 Jan;6(1):142-153. doi: 10.1002/cam4.976. Epub 2016 Dec 17.

18.

Efficacy of postoperative radiotherapy in patients with pathological stage N2 epidermal growth factor receptor wild type adenocarcinoma and squamous cell carcinoma lung cancer.

Lin YK, Hsu HL, Lin WC, Chang JH, Chang YC, Chang CL, Yuan KS, Wu ATH, Wu SY.

Oncotarget. 2017 May 23;8(21):35280-35288. doi: 10.18632/oncotarget.13257.

19.

Statins improve outcomes of nonsurgical curative treatments in hepatocellular carcinoma patients.

Wu LL, Hsieh MC, Chow JM, Liu SH, Chang CL, Wu SY.

Medicine (Baltimore). 2016 Sep;95(36):e4639. doi: 10.1097/MD.0000000000004639.

20.

Chinese Herbal Mixture, Tien-Hsien Liquid, Induces G2/M Cycle Arrest and Radiosensitivity in MCF-7 Human Breast Cancer Cells through Mechanisms Involving DNMT1 and Rad51 Downregulation.

Yao CJ, Chow JM, Yang CM, Kuo HC, Chang CL, Lee HL, Lai IC, Chuang SE, Lai GM.

Evid Based Complement Alternat Med. 2016;2016:3251046. doi: 10.1155/2016/3251046. Epub 2016 Jul 20.

Supplemental Content

Loading ...
Support Center